News

Brief news reports on Tuberculosis

UGA researcher receives $2.82 million grant to track tuberculosis transmissions in Africa

Athens, Ga. – Christopher Whalen, the Ernest Corn Professor of Epidemiology in the department of epidemiology and biostatistics in the University of Georgia College of Public Health, has received a five-year, $2.82 million grant to understand how tuberculosis is transmitted in urban environments in Africa.

Read More →

Video: World TB Day congressional briefing

A briefing and update on tuberculosis (TB), a disease that is curable but still takes the lives of 4,000 people each day and is the number one killer of people living with HIV. Special areas of focus of the briefing include US global leadership on TB, how communities are addressing the crisis, the threat of drug-resistant TB, and progress towards an effective vaccine, better medications and faster diagnostics.

Read More →

Life-saving drug on hold

Despite a request by non-government organisations for the drug to be made available for compassionate use, the Medicines Control Council has refused.

Read More →

Aeras and TBVI agree to strengthen collaboration on advancing new TB vaccines

27 April 2012 - Lelystad, The Netherlands and Rockville, USA - The Tuberculosis Vaccine Initiative (TBVI) and Aeras have signed a new memorandum of understanding to enhance and strengthen collaborative efforts to advance the world’s most promising tuberculosis (TB) vaccine candidates.

Read More →

Antiretroviral therapy as prevention: TB

Stephen Lawn reminded the audience at the International Treatment as Prevention Workshop in Vancouver on Wednesday that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB). The HIV-associated TB epidemic requires “radical interventions,” according to Lawn.  “DOTS [directly observed TB therapy, short course] just isn’t doing it.”

Read More →

New report finds that the US Government is the largest funder of global health R&D worldwide

Washington, DC (27 April 2012)—A new report finds that the United States government is the largest funder of global health research and development (R&D) in the world, investing $12.7 billion over the past 10 years in the creation of new vaccines, drugs, diagnostics, and other products for neglected diseases of the developing world. That funding, according to the report, helped lead to the development of more than half of the 45 new health products in the last decade that have been used to save lives around the world.

Read More →

People with TB and HIV in South Africa face a double stigma

People who have both tuberculosis (TB) and HIV experience “a unique and overlapping double stigma”, according to research published in the May issue of Social Science and Medicine. Having TB sends a signal that the person also has HIV. As a consequence, identities associated with TB are now strongly influenced by HIV stigma.

Read More →

Swaziland: Nurses demand protection from TB infection

MBABANE, 26 April 2012 (PlusNews) - Hospitals are not protecting their workers from tuberculosis (TB) infection, say nurses in Swaziland, who recently staged a rare public demonstration to draw attention to how vulnerable they are to this highly infectious disease.

Read More →

IOM releases summary of workshop on drug-resistant TB in India

 

Read More →

MDR, XDR, TDR tuberculosis: ominous progression

 

Read More →

Page 555 of 611 · Total posts: 10

←First 554 555 556 Last→